H. Wayne Lambert

Dr. H. Wayne Lambert

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2001 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
GBGennady A. Buznikov
Gennady A. Buznikov
HLH. Wayne Lambert
H. Wayne Lambert
JLJean M. Lauder
Jean M. Lauder

1 January 2016 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
MZMatthew J Zdilla
Matthew J Zdilla
SHScott A. Hatfield
Scott A. Hatfield
KMKennedy A. McLean
Kennedy A. McLean
LCLeah M. Cyrus
Leah M. Cyrus
JLJillian M. Laslo
Jillian M. Laslo
HLH. Wayne Lambert
H. Wayne Lambert
The structure of the foramen ovale of the sphenoid bone is clinically important, particularly with regard to surgical procedures that cannulate the foramen such as percutaneous trigeminal rhizotomy for the treatment of trigeminal neuralgia, percutaneous biopsy of parasellar lesions, and electroencephalographic analysis of the temporal lobe among patients undergoing selective amygdalohippocampectomy. Differences in the morphology of the foramen ovale (FO) have been reported to contribute to difficulties in the cannulation of the FO. Reports regarding the structure of the FO, however, use subjective and ambiguous descriptions of morphology, including “oval,” “truly oval,” “elongated oval,” “elongated,” “semicircular,” “almond,” “round,” “rounded,” “slit,” “irregular,” “D shape,” and “pear.” Therefore, it is necessary to describe the structure of the FO with reproducible objective morphometric data. This study analyzed 169 foramina to determine normative morphometric shape descriptions of the following: area, perimeter, circularity, solidity, axes of a best fit ellipse, aspect ratio, and roundness. The shape descriptors reported herein may aid in identification and description of structural variation in FO including bony projections encroaching upon the foramina and may improve surgical approaches to transovale cannulation.

1 October 2012 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
OAOlujimi A. Ajijola
Olujimi A. Ajijola
JWJonathan J. Wisco
Jonathan J. Wisco
HLH. Wayne Lambert
H. Wayne Lambert
AMAman Mahajan
Aman Mahajan
ESElena Stark
Elena Stark
KSKalyanam Shivkumar
Kalyanam Shivkumar
Background—: Intramyocardial nerve sprouting after myocardial infarction is associated with ventricular arrhythmias. Whether human stellate ganglia remodel in association with cardiac pathology is unknown. The purpose of this study was to determine whether cardiac pathology is associated with remodeling of the stellate ganglia in humans. Methods and Results—: Left stellate ganglia were collected from patients undergoing sympathetic denervation for intractable ventricular arrhythmias and from cadavers, along with intact hearts. Clinical data on patients and cadaveric subjects were reviewed. We classified ganglia from normal, scarred, and nonischemic cardiomyopathic hearts without scar as NL (n=3), SCAR (n=24), and NICM (n=7), respectively. Within left stellate ganglia, neuronal size, density, fibrosis, synaptic density, and nerve sprouting were determined. Nerve density and sprouting were also quantified in cadaveric hearts. Mean neuronal size in normal, scarred, and nonischemic cardiomyopathic hearts without scar groups were 320±4 μm 2 , 372±10 μm 2 , and 435±10 μm 2 ( P =0.002), respectively. No significant differences in neuronal density and fibrosis were present between the groups. Synaptic density in ganglia from SCAR and NICM groups were 57.8±11.2 μm 2 /mm 2 ( P =0.084) and 44.5±7.9 μm 2 /mm 2 ( P =0.039), respectively, compared with the normal group, 17.8±7 μm 2 /mm 2 (overall P =0.162). There were no significant differences in left stellate ganglia nerve sprouting or myocardial nerve density between the groups. Conclusions—: Neuronal hypertrophy within left stellate ganglia is associated with chronic cardiomyopathy in humans. Ganglionic and myocardial nerve sprouting and nerve density were not significantly different. These changes may be related to increased cardiac sympathetic signaling and ventricular arrhythmias. Further studies are needed to determine the electrophysiological consequences of extracardiac neuronal remodeling in humans.

1 January 2013 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Open access
PDF file
JBJoseph A. Blackmon
Joseph A. Blackmon
SAStavros Atsas
Stavros Atsas
MCMackenzie J. Clarkson
Mackenzie J. Clarkson
JFJacob N. Fox
Jacob N. Fox
BDBlake T. Daney
Blake T. Daney
HLH. Wayne Lambert
H. Wayne Lambert
The sural nerve is at risk of iatrogenic injury even during minimally invasive operative procedures to repair the calcaneal (Achilles) tendon. Through 107 cadaveric leg dissections, the data derived from the present study was used to develop a regression equation that will enable surgeons to estimate the intersection point at which the sural nerve crosses the lateral border of the Achilles tendon, an important surgical landmark. In most cases, the sural nerve crossed the lateral border of the Achilles tendon 8 to 10 cm proximal to the superior border of the calcaneal tuberosity. By simply measuring the leg length of the patient (from the base of the heel to the flexor crease of the popliteal fossa), surgeons can approximate the location of this intersection point with an interval length of 0.68 to 1.80 cm, with 90% confidence, or 0.82 to 2.15 cm, with 95% confidence. For example, for a patient with a lower leg length of 47.0 cm, the mean measurement in the present study, a surgeon can be 90% confident that the sural nerve will cross the lateral border of the Achilles tendon 8.28 to 8.96 cm (interval width of 0.68 cm) proximal to the calcaneal tuberosity. Currently, ultrasound and clinical techniques have been implemented to approximate the location of the sural nerve. The results of the present study offer surgeons another method, that is less intensive, to locate reliably and subsequently avoid damage to the sural nerve during calcaneal (Achilles) tendon repair and other procedures of the posterolateral leg and ankle.

16 August 2011 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
AMAbie H. Mendelsohn
Abie H. Mendelsohn
ADAdam DeConde
Adam DeConde
HLH. Wayne Lambert
H. Wayne Lambert
SDSean C. Dodson
Sean C. Dodson
BDBlake T. Daney
Blake T. Daney
Jonathan J. WiscoJonathan J. Wisco
Jonathan J. Wisco

1 February 2001 in Developmental Neuroscience
Verified
Journal Article
Closed access
PDF file
HLH. Wayne Lambert
H. Wayne Lambert
EWEllen R. Weiss
Ellen R. Weiss
JLJean M. Lauder
Jean M. Lauder
Results of the present study demonstrate that activation of the adenylyl cyclase/protein kinase A (PKA) pathway leads to increased levels of insulin-like growth factor I (IGF-I) in cultured embryonic mouse mandibular mesenchymal cells. Treatment of serum-free cultures with 10–8M 8-OH-DPAT (DPAT) or with 10–5M forskolin in the presence of the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX; 10–5M) increased levels of IGF-I (but not IGF-II), as measured by [125I]protein A immunobinding. In a previous study, we showed that DPAT, forskolin, IBMX and the 5-HT4 receptor agonist SC53116 all increased the synthesis of cyclic adenosine monophosphate (cAMP) in these cultures. Taken together, these results provide evidence that stimulation of the adenylyl cyclase/PKA pathway in embryonic mandibular mesenchymal cells positively regulates IGF-I. This is supported by the ability of the PKA inhibitor Rp-cAMPS to block increases in IGF-I caused by both DPAT and forskolin. Consistent with these results, DPAT and forskolin increased phosphorylation of the cAMP response element binding protein (CREB), which was also blocked by Rp-cAMPS. These results suggest that activation of 5-HT receptors positively coupled to the adenylyl cyclase/PKA pathway may promote transcription of IGF-I through a cAMP response element (CRE) in the IGF-I promoter. This may represent one mechanism whereby 5-HT positively regulates IGF-I expression in developing craniofacial mesenchymal cells.